Tamara Maes
unknown
Tamara Maes is exiting the board of Oryzon Genomics, having contributed to the company’s mission of advancing psychiatric treatments during her tenure.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Tamara Maes is set to leave the Oryzon board.
5
Carlos Buesa
Pierre Beaurang
Konstantinos Alataris
Montse Vendrell
Luis Sanchez Quintana
Ramon Adell
Isabel Aguilera
Antonio Fornieles
Josep Maria Echarri
El País: Oryzon duplica su valor en Bolsa desde enero con sus últimos avances en tratamientos en psiquiatría | Empresas